Literature DB >> 1554827

Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis.

M Venditti1, F De Bernardis, A Micozzi, E Pontieri, P Chirletti, A Cassone, P Martino.   

Abstract

An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B. The patient was a 21-year-old man who underwent colectomy for diffuse polyposis and developed the clinical syndrome just described following total parenteral nutrition for the treatment of purulent anal fistulas. Fluconazole was initially administered at a daily dose of 200 mg, with 600 mg daily given after 4 weeks. Clinical improvement resulted, with no relapse during 14 months of follow-up. Sequential measurements by an enzyme-linked immunosorbent inhibition assay demonstrated that levels of circulating mannoprotein antigen of C. albicans fell from 75 ng/mL to less than 1 ng/mL after the institution of fluconazole therapy. These observations seem to confirm previous reports on the efficacy of fluconazole as sole therapy for candidal endocarditis and suggest a role for serological studies in clinical monitoring of severe candidal infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554827     DOI: 10.1093/clinids/14.2.422

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Endophthalmitis as a first manifestation of right-sided endocarditis in a patient with patent foramen ovale.

Authors:  Ana Clara Rodrigues; Andrea Ogawa; Juliana Mota; Aime Carbone; Ana Lúcia Arruda; Meive Furtado; Jairo Pinheiro; José L Andrade
Journal:  J Echocardiogr       Date:  2012-03-24

2.  Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.

Authors:  A Louie; W Liu; D A Miller; A C Sucke; Q F Liu; G L Drusano; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

3.  Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.

Authors:  M G Agresti; F de Bernardis; F Mondello; R Bellocco; G P Carosi; R M Caputo; F Milazzo; F Chiodo; V Giannini; L Minoli
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

4.  Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease.

Authors:  C Girmenia; P Martino; F De Bernardis; A Cassone
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis.

Authors:  F De Bernardis; C Girmenia; M Boccanera; D Adriani; P Martino; A Cassone
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

Review 6.  Fungal endocarditis--a report on seven cases and a brief review.

Authors:  H Hogevik; K Alestig
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

7.  Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies.

Authors:  Murat Durdu; Mümtaz Güran; Hazal Kandemir; Macit Ilkit; Seyedmojtaba Seyedmousavi
Journal:  Mycopathologia       Date:  2015-09-04       Impact factor: 2.574

Review 8.  Diagnosis and treatment of invasive fungal infections in cancer patients.

Authors:  P Martino; C Girmenia
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

Review 9.  Clinical aspects of invasive candidiasis: endocarditis and other localized infections.

Authors:  Mario Venditti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

10.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.